アルコールの消費量アルコールの消費量

Same author

"Slow ahead": a response to the proposed heroin trial.

Drug and alcohol review·2005

Same author

Not much to ask for, really! The introduction of standard drink labelling in Australia.

Addiction (Abingdon, England)·2000

Same author

Conversation with David Hawks.

Addiction (Abingdon, England)·1998

Same author

Protecting the interests of participants in research into illicit drug use: two case studies.

Addiction (Abingdon, England)·1997

Same author

The new public health: nanny in a new hat?

Addiction (Abingdon, England)·1997

Same author

The drinks industry dilemma.

Addiction (Abingdon, England)·1996

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

アルコールの消費量アルコールの消費量

関連する概念動画

"Slow ahead": a response to the proposed heroin trial.

Not much to ask for, really! The introduction of standard drink labelling in Australia.

Conversation with David Hawks.

Protecting the interests of participants in research into illicit drug use: two case studies.

The new public health: nanny in a new hat?

The drinks industry dilemma.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

アルコールの消費量 アルコールの消費量

関連する概念動画

関連記事

"Slow ahead": a response to the proposed heroin trial.

Not much to ask for, really! The introduction of standard drink labelling in Australia.

Conversation with David Hawks.

Protecting the interests of participants in research into illicit drug use: two case studies.

The new public health: nanny in a new hat?

The drinks industry dilemma.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

アルコールの消費量アルコールの消費量